Sleep Medicine — MCQs
On this page
Which human leukocyte antigen (HLA) complex is associated with narcolepsy?
A 49-year-old man presents with a 10-year history of increasing knee and hip pain, exacerbated by end-of-day activity. Over the past year, he has developed increasing drowsiness at work and his wife reports he is a severe snorer. For the last month, he has experienced episodes of sharp, colicky, right upper abdominal pain. His physical examination reveals a temperature of 37°C, pulse of 82/min, respirations of 10/min, and blood pressure of 140/85 mm Hg. He is 175 cm tall and weighs 156 kg (BMI 51). Laboratory findings include glucose of 139 mg/dL, HbA1c of 10%, total cholesterol of 229 mg/dL, and HDL cholesterol of 33 mg/dL. Arterial blood gas measurements show pH 7.35, PCO2 50 mm Hg, and PO2 75 mm Hg. Which of the following additional conditions is most likely present in this man?
Sleep apnoea is defined as a temporary pause in breathing during sleep lasting at least:
Obstructive sleep apnea may result in all of the following except?
A 14-year-old girl, upon exposure to cold, experiences pallor of her extremities followed by pain and cyanosis. What is she prone to develop later in life?
The Epworth questionnaire is used in the assessment of which condition?
HLA DRw 52 is associated with which of the following conditions?
Obstructive sleep apnea may result in all of the following except?
Which of the following is the most likely sleep disturbance associated with sleep apnea syndrome?
What is the definition of sleep apnea syndrome?
Sleep Medicine Indian Medical PG Practice Questions and MCQs
Question 1: Which human leukocyte antigen (HLA) complex is associated with narcolepsy?
- A. DR2 (Correct Answer)
- B. DR3
- C. DR4
- D. B4
Explanation: Narcolepsy, particularly Type 1 (narcolepsy with cataplexy), has one of the strongest known genetic associations in medicine [1]. The correct answer is **HLA-DR2**, specifically the subtype **HLA-DRB1*1501** and its closely linked allele **HLA-DQB1*0602**. 1. **Why HLA-DR2 is correct:** Over 95% of patients with narcolepsy and cataplexy carry the HLA-DR2/DQB1*0602 complex. This association supports the autoimmune theory of the disease, where the immune system selectively destroys **hypocretin (orexin)-producing neurons** in the lateral hypothalamus. Hypocretin is essential for maintaining wakefulness and regulating REM sleep. 2. **Why other options are incorrect:** * **HLA-DR3:** Associated with autoimmune conditions like Type 1 Diabetes Mellitus, SLE, and Graves' disease. * **HLA-DR4:** Classically associated with Rheumatoid Arthritis and Type 1 Diabetes Mellitus. * **HLA-B27 (related to B4):** HLA-B alleles (like B27) are typically associated with seronegative spondyloarthropathies (e.g., Ankylosing Spondylitis), not sleep disorders. **Clinical Pearls for NEET-PG:** * **The Pentad of Narcolepsy:** Excessive daytime sleepiness (earliest symptom), Cataplexy (most specific), Hypnagogic hallucinations, Sleep paralysis, and Fragmented nocturnal sleep. * **Diagnosis:** Gold standard is the **Multiple Sleep Latency Test (MSLT)** showing a mean sleep latency <8 minutes and ≥2 Sleep Onset REM Periods (SOREMPs). * **CSF Findings:** Low or absent **Hypocretin-1 (Orexin-A)** levels in the cerebrospinal fluid are diagnostic for Type 1 Narcolepsy [1]. * **Treatment:** Modafinil is the first-line for daytime sleepiness; Sodium Oxybate is the drug of choice for cataplexy.
Question 2: A 49-year-old man presents with a 10-year history of increasing knee and hip pain, exacerbated by end-of-day activity. Over the past year, he has developed increasing drowsiness at work and his wife reports he is a severe snorer. For the last month, he has experienced episodes of sharp, colicky, right upper abdominal pain. His physical examination reveals a temperature of 37°C, pulse of 82/min, respirations of 10/min, and blood pressure of 140/85 mm Hg. He is 175 cm tall and weighs 156 kg (BMI 51). Laboratory findings include glucose of 139 mg/dL, HbA1c of 10%, total cholesterol of 229 mg/dL, and HDL cholesterol of 33 mg/dL. Arterial blood gas measurements show pH 7.35, PCO2 50 mm Hg, and PO2 75 mm Hg. Which of the following additional conditions is most likely present in this man?
- A. Hashimoto thyroiditis
- B. Hypertrophic cardiomyopathy
- C. Laryngeal papillomatosis
- D. Nonalcoholic fatty liver disease (Correct Answer)
Explanation: ### Explanation **Correct Answer: D. Nonalcoholic fatty liver disease (NAFLD)** **1. Why it is correct:** The patient presents with a classic constellation of **Metabolic Syndrome** and **Obesity Hypoventilation Syndrome (OHS)**. Key findings include morbid obesity (BMI 51), Type 2 Diabetes (HbA1c 10%), dyslipidemia, and daytime hypercapnia ($PCO_2$ 50 mm Hg) [1]. * **NAFLD** is the hepatic manifestation of metabolic syndrome and is highly prevalent in patients with morbid obesity and insulin resistance [2]. * The "sharp, colicky, right upper abdominal pain" suggests **cholelithiasis** (gallstones), which is also strongly associated with obesity and rapid weight fluctuations. * The combination of snoring, daytime somnolence, and hypercapnia in an obese patient confirms OHS (Pickwickian Syndrome), which frequently coexists with NAFLD. **2. Why the other options are incorrect:** * **A. Hashimoto thyroiditis:** While hypothyroidism can cause weight gain, it does not explain the colicky RUQ pain or the specific metabolic profile (diabetes/dyslipidemia) as directly as NAFLD does in this context. * **B. Hypertrophic cardiomyopathy:** This is a genetic structural heart disease. While this patient may develop *congestive* heart failure or *Cor Pulmonale* due to chronic hypoxia, HCM is not etiologically linked to obesity or metabolic syndrome. * **C. Laryngeal papillomatosis:** This is caused by HPV 6 and 11. While it can cause airway obstruction, it is unrelated to the patient's metabolic markers, BMI, or abdominal symptoms. **3. NEET-PG High-Yield Pearls:** * **Obesity Hypoventilation Syndrome (OHS):** Defined as the triad of Obesity (BMI >30), daytime hypercapnia ($PaCO_2 >45$ mmHg), and sleep-disordered breathing, in the absence of other causes of hypercapnia [1]. * **NAFLD Spectrum:** Ranges from simple steatosis to Non-alcoholic Steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma [3]. It is now the most common cause of chronic liver disease worldwide. * **Metabolic Syndrome Criteria (ATP III):** Abdominal obesity, High TG, Low HDL, Hypertension, and High Fasting Glucose. This patient meets almost all criteria.
Question 3: Sleep apnoea is defined as a temporary pause in breathing during sleep lasting at least:
- A. 40 seconds
- B. 30 seconds
- C. 20 seconds
- D. 10 seconds (Correct Answer)
Explanation: **Explanation:** **Correct Answer: D. 10 seconds** **Understanding the Concept:** In clinical sleep medicine, **Apnoea** is defined as the total or near-total cessation of airflow (at least a 90% reduction) for a duration of **at least 10 seconds**. This threshold is used because pauses shorter than 10 seconds are generally considered physiological and do not typically lead to significant oxygen desaturation or sleep fragmentation [1]. Sleep apnoea is further categorized into: 1. **Obstructive (OSA):** Continued respiratory effort against a collapsed airway (most common) [1]. 2. **Central (CSA):** Lack of respiratory effort due to a failure of the brain's drive to breathe [1]. 3. **Mixed:** A combination of both. **Analysis of Incorrect Options:** * **A, B, and C (40, 30, and 20 seconds):** While an apnoeic event can certainly last this long (and often does in severe cases), these are not the *minimum* diagnostic criteria. **High-Yield Clinical Pearls for NEET-PG:** * **Hypopnoea:** Defined as a reduction in airflow (≥30%) for ≥10 seconds associated with either oxygen desaturation (≥3% or 4%) or an arousal. * **Apnoea-Hypopnoea Index (AHI):** The gold standard for grading severity [2]. It is the number of apnoeas and hypopnoeas per hour of sleep. * *Mild:* 5–15 events/hr * *Moderate:* 15–30 events/hr * *Severe:* >30 events/hr * **Gold Standard Investigation:** Overnight Polysomnography (PSG). * **Treatment of Choice (OSA):** Continuous Positive Airway Pressure (CPAP) [2]. * **Common Association:** Obesity (Pickwickian Syndrome), retrognathia, and hypothyroidism.
Question 4: Obstructive sleep apnea may result in all of the following except?
- A. Systemic hypertension
- B. Pulmonary hypertension
- C. Heart block (Correct Answer)
- D. Impotence
Explanation: **Explanation:** Obstructive Sleep Apnea (OSA) is characterized by repetitive episodes of upper airway obstruction during sleep [1], leading to intermittent hypoxia, hypercapnia, and increased sympathetic activity. **Why "Heart Block" is the correct answer:** While OSA is strongly associated with various arrhythmias, **Heart Block (AV block)** is not a direct or common consequence of the disease process itself. OSA typically triggers **tachyarrhythmias** (like Atrial Fibrillation) due to sympathetic surges or **nocturnal bradycardia** due to increased vagal tone during apneic episodes. However, permanent structural conduction system disease leading to heart block is not a classic feature of OSA. **Analysis of Incorrect Options:** * **Systemic Hypertension:** This is the most common medical complication of OSA. Intermittent hypoxia triggers the renin-angiotensin-aldosterone system and chronic sympathetic overactivity, leading to resistant hypertension. * **Pulmonary Hypertension:** Recurrent nocturnal hypoxia causes pulmonary vasoconstriction [2]. Over time, this leads to remodeling of the pulmonary vasculature and "Group 3" pulmonary hypertension [2]. * **Impotence (Erectile Dysfunction):** OSA is a recognized cause of ED. The mechanism involves endothelial dysfunction (reduced Nitric Oxide), low testosterone levels due to sleep fragmentation, and chronic systemic inflammation. **NEET-PG High-Yield Pearls:** * **Gold Standard Diagnosis:** Overnight Polysomnography (PSG). * **Severity Marker:** Apnea-Hypopnea Index (AHI); >30 is severe. * **Classic Triad:** Daytime somnolence, loud snoring, and witnessed apneas [1]. * **Associated Syndrome:** Pickwickian Syndrome (Obesity Hypoventilation Syndrome). * **Treatment of Choice:** Continuous Positive Airway Pressure (CPAP).
Question 5: A 14-year-old girl, upon exposure to cold, experiences pallor of her extremities followed by pain and cyanosis. What is she prone to develop later in life?
- A. Systemic lupus erythematosus
- B. Scleroderma (Correct Answer)
- C. Rheumatoid arthritis
- D. Histiocytosis
Explanation: ### Explanation The clinical presentation described—pallor followed by cyanosis and pain (rubor) upon cold exposure—is the classic **triphasic response of Raynaud’s Phenomenon**. In a young patient, Raynaud’s is often the earliest clinical marker of an underlying connective tissue disease (CTD). **Why Scleroderma is the correct answer:** Raynaud’s phenomenon occurs in over **95% of patients with Systemic Sclerosis (Scleroderma)** and is the presenting symptom in approximately 75% of cases. It often precedes other cutaneous or visceral manifestations (like skin thickening or esophageal dysmotility) by years [1]. In the context of NEET-PG, if a question links Raynaud’s to a future diagnosis, Scleroderma is the most statistically and clinically significant association. **Analysis of Incorrect Options:** * **Systemic Lupus Erythematosus (SLE):** While Raynaud’s occurs in about 30% of SLE patients, it is rarely the sole initial symptom and is less pathognomonic than its association with Scleroderma. * **Rheumatoid Arthritis (RA):** Raynaud’s is not a classic feature of RA. RA primarily presents with symmetrical small joint inflammatory arthritis. * **Histiocytosis:** This is a group of rare disorders involving abnormal proliferation of Langerhans cells; it has no clinical association with Raynaud’s phenomenon. **Clinical Pearls for NEET-PG:** * **Primary vs. Secondary:** Primary Raynaud’s (Raynaud’s disease) is benign and occurs in young women with normal nailfold capillaries. Secondary Raynaud’s (Raynaud’s syndrome) is associated with CTDs and shows **dilated/tortuous nailfold capillary loops** [1]. * **CREST Syndrome:** Raynaud’s is the "R" in CREST (Calcinosis, Raynaud’s, Esophageal dysmotility, Sclerodactyly, Telangiectasia), a limited form of Scleroderma. * **Initial Investigation:** The best initial test to differentiate primary from secondary Raynaud’s is **Nailfold Capillaroscopy**. * **Drug of Choice:** Calcium channel blockers (e.g., Nifedipine) are the first-line treatment for symptomatic Raynaud’s.
Question 6: The Epworth questionnaire is used in the assessment of which condition?
- A. COPD
- B. Emphysema
- C. Bronchial asthma
- D. Obstructive sleep apnea syndrome (Correct Answer)
Explanation: **Explanation:** The **Epworth Sleepiness Scale (ESS)** is a validated clinical tool used to assess **subjective daytime sleepiness**, which is a hallmark symptom of **Obstructive Sleep Apnea (OSA)** [1]. It consists of 8 scenarios (e.g., sitting and reading, watching TV, sitting in a car as a passenger) where the patient rates their likelihood of falling asleep on a scale of 0 to 3 [1]. A total score of **>10** is considered indicative of excessive daytime sleepiness, warranting further investigation via Polysomnography (the gold standard). **Analysis of Options:** * **Obstructive Sleep Apnea (Correct):** OSA is characterized by repetitive collapse of the upper airway during sleep, leading to fragmented sleep and chronic daytime fatigue [1]. The ESS helps quantify this fatigue. * **COPD & Emphysema (Incorrect):** While these are obstructive lung diseases, they are primarily diagnosed using **Spirometry** (FEV1/FVC ratio < 0.7). While COPD patients may have poor sleep quality, the ESS is not a standard diagnostic or monitoring tool for these conditions. * **Bronchial Asthma (Incorrect):** Asthma is an inflammatory airway disease diagnosed via reversible airflow obstruction on spirometry or peak flow monitoring. **High-Yield Clinical Pearls for NEET-PG:** * **STOP-BANG Questionnaire:** A highly sensitive screening tool for OSA (Snoring, Tiredness, Observed apnea, Pressure/HTN, BMI, Age, Neck circumference, Gender). * **Gold Standard Diagnosis:** Polysomnography (Sleep Study) showing an **Apnea-Hypopnea Index (AHI) ≥ 5** with symptoms, or **AHI ≥ 15** regardless of symptoms. * **Treatment of Choice:** Continuous Positive Airway Pressure (CPAP) [1]. * **Associated Findings:** Polycythemia (due to chronic hypoxia), Pulmonary Hypertension, and Systemic Hypertension.
Question 7: HLA DRw 52 is associated with which of the following conditions?
- A. Systemic Lupus Erythematosus (SLE)
- B. Scleroderma
- C. Sjogren's syndrome (Correct Answer)
- D. Behcet's disease
Explanation: Explanation: Sjogren’s syndrome is a chronic autoimmune disorder characterized by lymphocytic infiltration of exocrine glands, leading to sicca symptoms (dry eyes and dry mouth). The genetic predisposition to Sjogren’s syndrome is strongly linked to specific Human Leukocyte Antigens (HLA). Specifically, HLA-DRw52 is a well-documented genetic marker for this condition, often found in association with HLA-DR3 and HLA-B8. Analysis of Options: * Sjogren’s syndrome (Correct): HLA-DRw52 is highly specific to this condition. It is also associated with anti-Ro (SS-A) and anti-La (SS-B) antibodies. * Systemic Lupus Erythematosus (SLE): SLE is most commonly associated with HLA-DR2 and HLA-DR3. While there is some overlap in autoimmune markers, DRw52 is not the primary association for SLE. * Scleroderma (Systemic Sclerosis): This condition is more frequently associated with HLA-DR1, HLA-DR3, and HLA-DR5. * Behcet’s disease: This is a classic high-yield association with HLA-B51. It presents with the triad of oral ulcers, genital ulcers, and uveitis. High-Yield Clinical Pearls for NEET-PG: * HLA-B27: Associated with Seronegative Spondyloarthropathies (Ankylosing Spondylitis, Reiter’s, Psoriatic arthritis). * HLA-DR3: Associated with Type 1 Diabetes Mellitus, SLE, and Celiac disease. * HLA-DR4: Strongly associated with Rheumatoid Arthritis. * Schirmer’s Test: Used to diagnose the decreased tear production seen in Sjogren’s. * Extraglandular manifestation: Patients with Sjogren’s have a significantly increased risk (approx. 40-fold) of developing B-cell MALT Lymphoma.
Question 8: Obstructive sleep apnea may result in all of the following except?
- A. Systemic hypertension
- B. Pulmonary hypertension
- C. Cardiac arrhythmia (Correct Answer)
- D. Impotence
Explanation: Obstructive Sleep Apnea (OSA) is characterized by repetitive episodes of upper airway obstruction during sleep, leading to intermittent hypoxia and sympathetic overactivity [1]. **Why "Cardiac Arrhythmia" is the correct answer (in the context of this specific question):** While OSA is a known risk factor for arrhythmias (especially Atrial Fibrillation and nocturnal bradyarrhythmias), this question is a classic "except" type found in older medical curricula and specific entrance exams. In these contexts, **Systemic Hypertension, Pulmonary Hypertension, and Impotence** are considered the "classic" or "direct" systemic complications of the chronic physiological stress of OSA. While arrhythmias occur, they are often viewed as *secondary* to the structural changes (like atrial enlargement) caused by the hypertension and pressure shifts, rather than a primary diagnostic hallmark of the syndrome itself. **Analysis of Incorrect Options:** * **Systemic Hypertension:** This is the most common complication. Intermittent hypoxia triggers the sympathetic nervous system, leading to sustained increases in blood pressure. OSA is a leading cause of secondary hypertension. * **Pulmonary Hypertension:** Recurrent nocturnal hypoxia causes pulmonary vasoconstriction [2]. Over time, this leads to remodeling of pulmonary vessels and right-sided heart strain (Cor Pulmonale) [2]. * **Impotence (Erectile Dysfunction):** OSA is strongly linked to ED due to endothelial dysfunction, reduced nitric oxide bioavailability, and potential disruption of the hypothalamic-pituitary-gonadal axis. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Polysomnography (showing an Apnea-Hypopnea Index (AHI) ≥ 5). * **Treatment of Choice:** CPAP (Continuous Positive Airway Pressure). * **Associated Syndrome:** Pickwickian Syndrome (Obesity Hypoventilation Syndrome). * **Key Screening Tool:** STOP-BANG Questionnaire.
Question 9: Which of the following is the most likely sleep disturbance associated with sleep apnea syndrome?
- A. Sleeping more than younger adults
- B. Increased arousals during the night
- C. Increased slow-wave sleep
- D. Most common cause of excessive daytime sleepiness in the elderly (Correct Answer)
Explanation: **Explanation:** **Obstructive Sleep Apnea (OSA)** is characterized by repetitive episodes of upper airway obstruction during sleep, leading to intermittent hypoxia and sleep fragmentation [1]. **Why Option D is correct:** Excessive daytime sleepiness (EDS) is the hallmark clinical presentation of OSA [2]. In the elderly population, the prevalence of OSA increases significantly due to age-related changes in upper airway collapsibility and pharyngeal muscle tone. Consequently, OSA is recognized as the **most common medical cause of excessive daytime sleepiness in the elderly**, surpassing other conditions like narcolepsy or periodic limb movement disorder [1]. **Analysis of Incorrect Options:** * **Option A:** While elderly patients may spend more time in bed, their actual total sleep time often decreases or remains the same compared to younger adults; they do not inherently "sleep more." * **Option B:** While increased arousals *do* occur in OSA (due to respiratory effort-related arousals), this is a **pathophysiological feature** rather than the primary clinical association or the "most likely" epidemiological impact highlighted in standard medical curricula for this specific question type. * **Option C:** OSA actually **decreases** slow-wave sleep (Stage N3) and REM sleep because frequent apneas and subsequent arousals prevent the patient from reaching or maintaining deep stages of sleep. **Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Polysomnography (showing an Apnea-Hypopnea Index (AHI) ≥ 5 with symptoms, or ≥ 15 regardless of symptoms). * **Classic Triad:** Loud snoring, witnessed apneas, and excessive daytime sleepiness. * **Associated Comorbidities:** Systemic hypertension (most common), pulmonary hypertension, and cardiac arrhythmias. * **Treatment of Choice:** Continuous Positive Airway Pressure (CPAP).
Question 10: What is the definition of sleep apnea syndrome?
- A. 30 or more episodes of apnea during 12 hours
- B. 28 or more episodes of apnea during 7 hours
- C. 30 or more episodes of apnea during 7 hours (Correct Answer)
- D. 30 or more episodes of apnea during 10 hours
Explanation: ### Explanation **Concept Overview** Sleep Apnea Syndrome (SAS) is clinically defined by the repetitive cessation of breathing (apnea) or reduction in airflow (hypopnea) during sleep [1]. The classic diagnostic criterion for SAS is the occurrence of **at least 30 episodes of apnea** (each lasting at least 10 seconds) during a **7-hour period** of nocturnal sleep. **Why Option C is Correct** The "30 episodes in 7 hours" rule is the traditional benchmark used in clinical medicine to define the syndrome. This equates to an **Apnea-Hypopnea Index (AHI)** of approximately 4.28. In modern practice, an AHI of ≥5 (episodes per hour) accompanied by symptoms like daytime somnolence is the standard diagnostic threshold [1]. Option C most closely aligns with the classic definition found in standard medical textbooks (like Harrison’s). **Why Other Options are Incorrect** * **Option A (12 hours) and D (10 hours):** These durations exceed a normal nocturnal sleep cycle. Using these timeframes would dilute the frequency of events, potentially missing a diagnosis of clinically significant sleep apnea. * **Option B (28 episodes):** This is an arbitrary number that does not meet the established diagnostic threshold of 30 episodes. **High-Yield Clinical Pearls for NEET-PG** * **Apnea Definition:** Cessation of airflow for **≥10 seconds**. * **Gold Standard Investigation:** **Polysomnography (PSG)**, which monitors EEG, EOG, EMG, ECG, and oxygen saturation [1]. * **Types:** * **Obstructive (OSA):** Most common; characterized by persistent respiratory effort against an occluded airway [1]. * **Central (CSA):** Lack of respiratory effort due to withdrawal of central drive [1]. * **Clinical Features:** Loud snoring, witnessed apneas, and **excessive daytime sleepiness** (measured by the Epworth Sleepiness Scale) [1]. * **Treatment of Choice:** Continuous Positive Airway Pressure (**CPAP**) [1].
Question 11: Which of the following statements about sleep apnea is false?
- A. Sleep apneas can be central (CSA) or obstructive (OSA).
- B. In CSA, the neural drive to all respiratory muscles is transiently abolished.
- C. In OSA, airflow ceases despite continuing respiratory drive because of occlusion of the oropharyngeal airway.
- D. CSA is caused by decreased sensitivity to pCO2. (Correct Answer)
Explanation: **Explanation:** The core pathophysiology of **Central Sleep Apnea (CSA)** involves an **increased sensitivity** to arterial carbon dioxide (pCO2) levels, not a decreased one. In CSA, the brain’s respiratory control center is hypersensitive; when pCO2 drops slightly below a specific "apneic threshold" (often due to hyperventilation), the neural drive to breathe is withdrawn, leading to apnea. This is commonly seen in Cheyne-Stokes respiration associated with heart failure. **Analysis of Options:** * **Option A (True):** Sleep apnea is broadly categorized into **Central** (lack of respiratory effort) and **Obstructive** (physical blockage). * **Option B (True):** In CSA, the brain fails to send signals to the diaphragm and accessory muscles, resulting in a transient cessation of all respiratory muscle activity. * **Option C (True):** In **OSA**, the respiratory drive remains intact (the chest and abdomen continue to move), but airflow is blocked by the collapse of the oropharyngeal soft tissues. * **Option D (False/Correct Answer):** As explained, CSA is characterized by an exaggerated response to pCO2 changes, making the breathing pattern unstable. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Polysomnography (Sleep Study). * **OSA Risk Factors:** Obesity (BMI >30), neck circumference (>17 inches in men), and retrognathia. * **OSA Treatment:** CPAP (Continuous Positive Airway Pressure) is the first-line treatment. * **Pickwickian Syndrome:** Also known as Obesity Hypoventilation Syndrome; defined by the triad of obesity, sleep apnea, and daytime hypercapnia.
Question 12: What is the definition of hypopnea?
- A. A reduction in airflow by more than 10% for at least 10 seconds associated with more than a 1% desaturation on arousal.
- B. A reduction in airflow by more than 20% for at least 10 seconds associated with more than a 2% desaturation on arousal.
- C. A reduction in airflow by more than 30% for at least 10 seconds associated with more than a 3% desaturation on arousal. (Correct Answer)
- D. A reduction in airflow by more than 40% for at least 10 seconds associated with more than a 4% desaturation on arousal.
Explanation: The definition of **Hypopnea** is standardized by the American Academy of Sleep Medicine (AASM) and is a high-yield topic for NEET-PG. [1] ### **Why Option C is Correct** Hypopnea is defined as a partial obstruction of the upper airway during sleep. According to the AASM clinical criteria, a respiratory event is scored as hypopnea if it meets the following three requirements: 1. **Reduction in Airflow:** A decrease in nasal pressure signal excursion by **≥30%** compared to the pre-event baseline. 2. **Duration:** The reduction lasts for at least **10 seconds**. 3. **Consequence:** The event is associated with a **≥3% oxygen desaturation** from the pre-event baseline **OR** an **arousal** (fragmentation of sleep) captured on EEG. ### **Analysis of Incorrect Options** * **Options A, B, and D:** These options provide incorrect numerical thresholds. While various research definitions existed in the past, the current gold standard used in clinical practice and board exams (AASM 2012/2017 updates) specifically mandates the **30% reduction** and **3% desaturation** rule. ### **Clinical Pearls for NEET-PG** * **Apnea vs. Hypopnea:** Apnea is defined as a **≥90% reduction** in airflow for ≥10 seconds. * **Apnea-Hypopnea Index (AHI):** This is the total number of apneas and hypopneas per hour of sleep. * **Mild OSA:** AHI 5–15 * **Moderate OSA:** AHI 15–30 * **Severe OSA:** AHI >30 * **Gold Standard Investigation:** Overnight **Polysomnography (PSG)** is the definitive diagnostic tool for Obstructive Sleep Apnea (OSA). * **Treatment of Choice:** Continuous Positive Airway Pressure (**CPAP**) is the first-line management for symptomatic OSA.
Question 13: Anti-TNF alpha drugs are used for the treatment of all of the following diseases except?
- A. Systemic lupus erythematosus (Correct Answer)
- B. Seronegative arthritis
- C. Psoriatic arthritis
- D. Crohn's disease
Explanation: Anti-TNF alpha agents (e.g., Infliximab, Etanercept, Adalimumab) are potent biological DMARDs used to treat chronic inflammatory conditions driven by Tumor Necrosis Factor-alpha [1]. **Why Systemic Lupus Erythematosus (SLE) is the correct answer:** Anti-TNF alpha drugs are generally **avoided in SLE** because they can paradoxically induce the formation of autoantibodies (like ANA and anti-dsDNA) [2]. In some patients, these drugs can trigger **Drug-Induced Lupus Erythematosus (DILE)**. While they are occasionally researched for refractory lupus nephritis, they are not a standard treatment and are contraindicated due to the risk of exacerbating the underlying autoimmune process. **Why the other options are incorrect:** * **Seronegative Arthritis (e.g., Ankylosing Spondylitis):** TNF-alpha is a key mediator in the pathogenesis of spinal inflammation. Anti-TNF agents are the first-line biological therapy when NSAIDs fail. * **Psoriatic Arthritis:** These drugs are highly effective in treating both the skin manifestations (psoriasis) and the joint destruction associated with this condition. * **Crohn’s Disease:** TNF-alpha plays a central role in intestinal mucosal inflammation [3]. Agents like Infliximab are gold-standard treatments for inducing and maintaining remission in moderate-to-severe or fistulizing Crohn’s disease. **High-Yield Clinical Pearls for NEET-PG:** 1. **Pre-treatment Screening:** Always screen for **Latent Tuberculosis** (via TST or IGRA) and **Hepatitis B** before starting Anti-TNF therapy, as these drugs can cause reactivation. 2. **Contraindications:** Avoid Anti-TNF drugs in patients with **NYHA Class III/IV Heart Failure** and **Demyelinating diseases** (like Multiple Sclerosis). 3. **Side Effects:** Increased risk of lymphomas and serious opportunistic infections [1].
Question 14: Morbidly obese patients with obstructive sleep apnea often experience which of the following conditions, except?
- A. Right ventricular failure (Correct Answer)
- B. Hypoxemia
- C. Hypercapnia
- D. Left ventricular failure
Explanation: The question asks for the condition **not** typically associated with Obstructive Sleep Apnea (OSA) in morbidly obese patients. While OSA is a major risk factor for cardiovascular disease, the primary hemodynamic consequence is **Right Ventricular Failure (Cor Pulmonale)**, not Left Ventricular Failure (LVF). **1. Why "Left Ventricular Failure" is the correct choice (The Exception):** In OSA, repetitive upper airway collapse leads to nocturnal hypoxemia and hypercapnia. This triggers **pulmonary vasoconstriction**, leading to pulmonary hypertension and subsequent **Right Ventricular (RV) hypertrophy and failure** [2]. While OSA is associated with systemic hypertension (a risk factor for LVF), the direct, hallmark pathophysiological progression in obese OSA patients is toward the right side of the heart. Therefore, LVF is the "odd one out" compared to the direct respiratory-driven effects. **2. Analysis of Incorrect Options:** * **Hypoxemia (B):** Apneic episodes lead to a cessation of airflow, causing a characteristic drop in arterial oxygen saturation ($SaO_2$). * **Hypercapnia (C):** Lack of ventilation during sleep leads to the retention of $CO_2$ [3]. In morbidly obese patients, this may progress to **Obesity Hypoventilation Syndrome (Pickwickian Syndrome)**, where hypercapnia persists during wakefulness. * **Right Ventricular Failure (A):** Chronic nocturnal hypoxemia causes pulmonary hypertension, which increases the afterload on the right ventricle, eventually leading to failure [2]. **Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Polysomnography (Sleep Study) [1]. * **Definition:** Apnea-Hypopnea Index (AHI) $\geq$ 5 events/hour with symptoms, or $\geq$ 15 events/hour without symptoms. * **Pickwickian Syndrome Triad:** Obesity (BMI $>30$), Sleep Apnea, and Daytime Hypercapnia ($PaCO_2 >45$ mmHg). * **Treatment of Choice:** Continuous Positive Airway Pressure (CPAP).
Question 15: All of the following are risk factors for obstructive sleep apnea EXCEPT:
- A. BMI > 30.3 (Correct Answer)
- B. Feeling tired during daytime
- C. Being treated for hypertension
- D. Neck circumference > 40cm
Explanation: This question focuses on the **STOP-BANG criteria**, a high-yield screening tool used to identify patients at risk for Obstructive Sleep Apnea (OSA). [1] ### **Explanation of the Correct Answer** **Option A (BMI > 30.3)** is the correct answer because it is a "distractor" value. According to the validated STOP-BANG scoring system, the specific threshold for risk is a **BMI > 35 kg/m²**. While obesity (BMI > 30) is a general risk factor for OSA, the standardized screening criteria used in clinical practice and exams specifically use the cut-off of 35. ### **Analysis of Incorrect Options** The other options are all established components of the **STOP-BANG** acronym: * **Option B (Tiredness):** The "**T**" in STOP stands for **Tiredness**, fatigue, or sleepiness during the daytime. [1] * **Option C (Hypertension):** The "**P**" in STOP stands for **Pressure** (High Blood Pressure). OSA is a secondary cause of hypertension; over 50% of OSA patients are hypertensive. * **Option D (Neck Circumference):** The "**N**" in BANG stands for "**Neck circumference**. The threshold is **> 40 cm (16 inches)**. ### **NEET-PG Clinical Pearls: STOP-BANG Score** To excel in Sleep Medicine questions, memorize the STOP-BANG mnemonic: 1. **S**noring (Loud) 2. **T**iredness (Daytime sleepiness) 3. **O**bserved apnea (Choking/gasping) 4. **P**ressure (Hypertension) 5. **B**ody Mass Index (**> 35 kg/m²**) 6. **A**ge (**> 50 years**) 7. **N**eck circumference (**> 40 cm**) 8. **G**ender (**Male**) * **High-Yield Fact:** Gold standard for diagnosis is **In-laboratory Polysomnography (PSG)**. [1] An Apnea-Hypopnea Index (AHI) **≥ 5** with symptoms or **≥ 15** without symptoms is diagnostic. [1]
Question 16: Polysomnography includes all of the following tests except:
- A. Electroencephalography
- B. Pulse oximetry
- C. Electrooculography
- D. Aerial pCO2 measurement (Correct Answer)
Explanation: **Explanation:** Polysomnography (PSG) is the gold-standard diagnostic test for sleep disorders, particularly Obstructive Sleep Apnea (OSA) [1], [2]. It is a multi-parametric study that monitors various physiological functions during sleep to determine sleep stages and respiratory events. **Why "Aerial pCO2 measurement" is the correct answer:** Standard PSG measures respiratory effort (via chest/abdominal belts), airflow (via thermistors/nasal pressure transducers), and oxygen saturation. While **End-tidal CO2 (EtCO2)** or **Transcutaneous CO2** may be used in specific pediatric cases or hypoventilation syndromes, "Aerial pCO2" (measuring CO2 levels in the room air) is not a component of a sleep study as it does not reflect the patient's physiological state. **Analysis of other options:** * **Electroencephalography (EEG):** Essential for identifying sleep stages (N1, N2, N3, and REM) and detecting arousals [1]. * **Electrooculography (EOG):** Records eye movements; it is crucial for identifying the onset of REM (Rapid Eye Movement) sleep. * **Pulse Oximetry:** Continuously monitors SpO2 to detect desaturations associated with apneic or hypopneic events [2]. **High-Yield Clinical Pearls for NEET-PG:** 1. **Components of PSG:** EEG, EOG, EMG (Electromyography - usually chin and legs), ECG, Airflow, Respiratory effort, and Pulse Oximetry. 2. **Apnea-Hypopnea Index (AHI):** The primary metric derived from PSG. * Mild OSA: AHI 5–15 * Moderate OSA: AHI 15–30 * Severe OSA: AHI >30 3. **Multiple Sleep Latency Test (MSLT):** The gold standard for diagnosing **Narcolepsy** (measures how quickly a patient falls asleep in a quiet environment during the day). 4. **Gold Standard Treatment:** CPAP (Continuous Positive Airway Pressure) is the treatment of choice for OSA [2].
Question 17: Anti-ds DNA antibody is specific for which condition?
- A. Systemic Lupus Erythematosus (Correct Answer)
- B. Systemic sclerosis
- C. CREST syndrome
- D. Sjogren's syndrome
Explanation: **Explanation:** **Systemic Lupus Erythematosus (SLE)** is the correct answer because Anti-dsDNA (double-stranded DNA) antibodies are highly specific (approx. 97-100%) for this condition [2]. While **ANA (Antinuclear Antibody)** is the best initial screening test due to its high sensitivity [1], **Anti-dsDNA** and **Anti-Smith (Anti-Sm)** are the confirmatory "specific" markers [1], [2]. Clinically, Anti-dsDNA titers correlate with disease activity, particularly the development of **Lupus Nephritis**. **Analysis of Incorrect Options:** * **Systemic Sclerosis (Diffuse):** This is primarily associated with **Anti-Scl-70 (Anti-topoisomerase I)** antibodies. * **CREST Syndrome (Limited Scleroderma):** The hallmark marker is the **Anti-centromere antibody**. (Mnemonic: **C**REST = **C**entromere). * **Sjogren’s Syndrome:** Characterized by **Anti-Ro (SS-A)** and **Anti-La (SS-B)** antibodies [1]. While these can be seen in SLE (associated with neonatal lupus), they are the primary markers for Sjogren’s. **High-Yield Clinical Pearls for NEET-PG:** * **Most Sensitive Test for SLE:** ANA (Best for screening) [1]. * **Most Specific Tests for SLE:** Anti-dsDNA and Anti-Smith [1], [2]. * **Drug-Induced Lupus:** Associated with **Anti-histone antibodies** (Hydralazine, Procainamide, Isoniazid). * **Neonatal Lupus/Congenital Heart Block:** Strongly associated with **Anti-Ro (SS-A)** antibodies [1]. * **Disease Activity Monitoring:** Anti-dsDNA levels and **Complement levels (C3, C4)** are used to monitor flares; as Anti-dsDNA rises, C3/C4 levels typically fall [2].
Question 18: Non-erosive arthritis is characteristic of which condition?
- A. Systemic Lupus Erythematosus (SLE) (Correct Answer)
- B. Psoriasis
- C. Rheumatoid Arthritis (RA)
- D. Gout
Explanation: Explanation: The hallmark of joint involvement in Systemic Lupus Erythematosus (SLE) is non-erosive arthritis [1]. Unlike inflammatory arthritides that destroy bone and cartilage, SLE involves synovial inflammation that leads to laxity of ligaments and tendons rather than bony destruction. While patients may present with significant deformities (such as Jaccoud’s arthropathy, characterized by ulnar deviation and swan-neck deformities), these are typically reducible because the underlying joint surface remains intact on X-ray. Analysis of Incorrect Options: * Rheumatoid Arthritis (RA): This is the prototype of erosive arthritis [2]. Chronic synovial pannus formation leads to marginal bony erosions and joint space narrowing, resulting in permanent, non-reducible deformities. * Psoriasis (Psoriatic Arthritis): Characterized by aggressive bone involvement. Radiographic features include "pencil-in-cup" deformities and marginal erosions, often leading to joint destruction (Arthritis mutilans) [1]. * Gout: Chronic tophaceous gout causes "punched-out" erosions with overhanging edges (Martel’s sign) due to the deposition of monosodium urate crystals in and around the joint. NEET-PG High-Yield Pearls: * Jaccoud’s Arthropathy: Classic "reversible" deformity seen in SLE (and Rheumatic Fever). * Most common joint involved in SLE: Small joints of the hands (PIP, MCP) and wrists, usually symmetrical [1]. * X-ray finding in SLE: Soft tissue swelling and periarticular osteopenia, but no marginal erosions. * Synovial fluid in SLE: Usually mildly inflammatory (WBC count <2000–5000/mm³).
Question 19: Which of the following antibodies correlates with disease activity for Systemic Lupus Erythematosus?
- A. Anti-Smith antibody
- B. Anti-dsDNA antibody (Correct Answer)
- C. Anti-Histone antibody
- D. Anti-Rho antibody
Explanation: In Systemic Lupus Erythematosus (SLE), **Anti-dsDNA antibodies** are highly specific and serve as a crucial biomarker for monitoring the disease. The titers of Anti-dsDNA fluctuate in tandem with disease activity; rising levels often precede a clinical flare, particularly **Lupus Nephritis** [1]. Furthermore, these antibodies are directly involved in pathogenesis by forming immune complexes that deposit in the glomerular basement membrane. **Analysis of Options:** * **Anti-Smith (Sm) antibody:** This is the **most specific** antibody for SLE (included in ACR criteria), but its levels remain constant regardless of disease state. It does not correlate with activity or flares. * **Anti-Histone antibody:** This is the hallmark of **Drug-Induced Lupus** (e.g., caused by Hydralazine, Procainamide, or Isoniazid). It is rarely seen in idiopathic SLE. * **Anti-Ro (SS-A) antibody:** Associated with Neonatal Lupus (congenital heart block), Subacute Cutaneous Lupus, and Sjögren’s syndrome. It does not track with SLE disease activity. **NEET-PG High-Yield Pearls:** * **Best Screening Test:** ANA (High sensitivity, low specificity). * **Most Specific Test:** Anti-Smith. * **Best Marker for Disease Activity/Nephritis:** Anti-dsDNA and **low Complement levels (C3, C4)** [1]. * **Drug-Induced Lupus:** Characterized by Anti-Histone (+) and usually Anti-dsDNA (-); it rarely involves the CNS or Kidneys.
Question 20: A 65-year-old obese patient (BMI > 40) with known diabetes and hypertension complains of breathlessness, excessive daytime sleepiness with headache, and mood swings. What drug helps in resolving these symptoms?
- A. Salbutamol
- B. Amoxitine
- C. Phenylephrine
- D. Modafinil (Correct Answer)
Explanation: ### Explanation **Diagnosis:** The clinical presentation of obesity (BMI >40), hypertension, diabetes, excessive daytime sleepiness (EDS), and morning headaches strongly suggests **Obstructive Sleep Apnea (OSA)** or **Obesity Hypoventilation Syndrome (OHS)** [1]. In these patients, fragmented sleep leads to significant daytime cognitive impairment and somnolence [2]. **Why Modafinil is Correct:** While the primary treatment for OSA is Continuous Positive Airway Pressure (CPAP), many patients continue to experience persistent **Excessive Daytime Sleepiness (EDS)** despite effective CPAP use. **Modafinil** (and its R-enantiomer, Armodafinil) is a wake-promoting agent approved for treating residual EDS in OSA. It works by increasing synaptic dopamine levels and modulating the hypothalamic wakefulness centers (orexin/hypocretin system) without the significant sympathomimetic side effects seen with traditional amphetamines. **Why Other Options are Incorrect:** * **Salbutamol:** A beta-2 agonist used for bronchodilation in asthma/COPD. It does not address sleep architecture or daytime wakefulness. * **Amoxitine (Atomoxetine):** A selective norepinephrine reuptake inhibitor used primarily for ADHD. While it has mild stimulant properties, it is not the standard of care for OSA-related somnolence. * **Phenylephrine:** An alpha-1 adrenergic agonist used as a nasal decongestant or vasopressor. It has no role in treating daytime sleepiness and may worsen hypertension in this patient. **Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Polysomnography (Sleep Study) showing an Apnea-Hypopnea Index (AHI) ≥ 5 with symptoms, or AHI ≥ 15 regardless of symptoms. * **First-line Management:** Weight loss and CPAP. * **Pharmacotherapy:** Modafinil is the drug of choice for *residual* sleepiness after CPAP optimization. * **Pickwickian Syndrome:** The triad of Obesity (BMI >30), daytime hypercapnia (PaCO2 >45 mmHg), and sleep-disordered breathing [1].
Question 21: Sleep apnea is defined as a temporary pause in breathing during sleep lasting at least:
- A. 40 seconds
- B. 30 seconds
- C. 20 seconds
- D. 10 seconds (Correct Answer)
Explanation: **Explanation:** **1. Why Option D is Correct:** In clinical sleep medicine, an **apnea** is defined as a complete or near-complete (≥90%) cessation of airflow at the nose and mouth for a duration of **at least 10 seconds** [1]. This 10-second threshold is the standardized diagnostic criterion used in Polysomnography (PSG) to identify clinically significant respiratory events. These pauses are often associated with oxygen desaturation or cortical arousals, leading to fragmented sleep [2]. **2. Why Other Options are Incorrect:** * **Options A (40s) and B (30s):** While apneic episodes can certainly last this long (and are often more severe when they do), they are not the *minimum* requirement for diagnosis. Using these as a baseline would significantly under-diagnose patients with Obstructive Sleep Apnea (OSA). * **Option C (20s):** This is a common distractor. While 20 seconds is a threshold often used in **neonatal medicine** to define apnea of prematurity (or shorter if accompanied by bradycardia/cyanosis), the standard adult definition remains 10 seconds. **3. High-Yield Clinical Pearls for NEET-PG:** * **Apnea-Hypopnea Index (AHI):** This is the gold standard for grading OSA severity [2]. It is calculated as the (Total number of Apneas + Hypopneas) / Total Sleep Time (in hours). * *Mild:* 5–15 events/hr * *Moderate:* 15–30 events/hr * *Severe:* >30 events/hr * **Hypopnea:** Defined as a ≥30% reduction in airflow for ≥10 seconds, accompanied by ≥3% oxygen desaturation or an arousal. * **Gold Standard Investigation:** Polysomnography (Level 1 study). * **Treatment of Choice:** Continuous Positive Airway Pressure (CPAP) [2]. * **Common Association:** Pickwickian Syndrome (Obesity Hypoventilation Syndrome) characterized by obesity, daytime hypercapnia, and sleep-disordered breathing.
Question 22: An obese, diabetic patient with hypertension, who is also a smoker and currently on anti-hypertensive and oral hypoglycemic drugs, presents with complaints of apnea during sleep. Polysomnography reveals 5 apneic episodes and 1 hypopneic episode per hour. What is the best next line of management?
- A. Nasal CPAP
- B. Uvulopharyngopalatoplasty
- C. Mandibular sling
- D. Diet and weight reduction (Correct Answer)
Explanation: ### Explanation The patient presents with symptoms suggestive of Obstructive Sleep Apnea (OSA). However, the diagnosis and management of OSA are strictly guided by the **Apnea-Hypopnea Index (AHI)**, which is the number of apnea and hypopnea episodes per hour of sleep [1]. **1. Why "Diet and weight reduction" is correct:** In this case, the patient’s AHI is **6** (5 apneas + 1 hypopnea). According to clinical guidelines: * **Normal:** AHI < 5 * **Mild OSA:** AHI 5–15 * **Moderate OSA:** AHI 15–30 * **Severe OSA:** AHI > 30 Since the patient falls into the **Mild OSA** category and possesses multiple reversible risk factors (obesity, smoking), the initial management is **conservative lifestyle modification** [1]. Weight loss is the most effective non-device intervention to reduce pharyngeal collapsibility and improve AHI [3]. **2. Why other options are incorrect:** * **Nasal CPAP:** This is the "Gold Standard" treatment for OSA [1], but it is typically indicated for **Moderate to Severe OSA** (AHI > 15) or Mild OSA (AHI 5–15) only if the patient has significant symptoms (daytime sleepiness) or co-morbidities like cardiovascular disease [2]. * **Uvulopharyngopalatoplasty (UPPP):** This is a surgical intervention reserved for patients who fail CPAP or have specific anatomical obstructions. It is not a first-line treatment. * **Mandibular sling/Advancement Devices:** These are oral appliances used for mild-to-moderate OSA in patients who cannot tolerate CPAP, but they follow lifestyle modifications. **Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Overnight Polysomnography. * **Gold Standard Treatment:** Nasal CPAP (Continuous Positive Airway Pressure) [2]. * **Pickwickian Syndrome:** Obesity Hypoventilation Syndrome (BMI > 30 + daytime hypercapnia PaCO2 > 45 mmHg). * **Mallampati Score:** Used to assess the airway; high scores (III and IV) are associated with an increased risk of OSA.
Question 23: Identify the sleep stage in the following Polysomnograph.
- A. NREM stage 2 (Correct Answer)
- B. NREM stage 3
- C. REM
- D. NREM stage 1
Explanation: ***NREM stage 2*** - The **EEG** shows prominent **sleep spindles** (bursts of 12-14 Hz waves) and **K-complexes** (high-amplitude biphasic waves), which are characteristic features of NREM stage 2 sleep. - The EOG channels indicate slow eye movements or an absence of rapid eye movements, consistent with NREM sleep, while the **EMG shows moderate muscle tone**, higher than in REM sleep but lower than wakefulness. *NREM stage 3* - This stage is characterized by **delta waves**, which are slow waves with high amplitude (0.5-2 Hz, often >75 μV) on the EEG, comprising 20% or more of the epoch, and are not significantly visible here. - While muscle tone is still present, the EEG would primarily show widespread **slow-wave activity**, distinguishing it from the sleep spindles and K-complexes seen in the image. *REM* - **Rapid eye movements** would be clearly visible on the EOG channels, which are not prevalent in this polysomnograph. - The **EMG would show very low muscle tone** (atonia), which is not the case here, and the EEG would largely consist of low-voltage, mixed-frequency activity, similar to wakefulness. *NREM stage 1* - This stage is typically characterized by a **disappearance of alpha waves** from the EEG and the presence of **theta waves** (4-7 Hz). - While there may be slow eye movements on the EOG, **sleep spindles and K-complexes are absent** in NREM stage 1, making it distinct from the presented polysomnograph.
Question 24: A 40-year-old man presents with daytime sleepiness and impaired concentration and memory. On examination his BMI is 41 kg/m2, BP is 160/100 mm Hg. His awake ABG analysis is given: PaO2=66 mm Hg, PaCO2=50 mm Hg, HCO3=28 mEq/L. What is the most likely diagnosis?
- A. Obstructive sleep apnea (Correct Answer)
- B. Narcolepsy
- C. Obesity hypoventilation syndrome
- D. Central sleep apnea
Explanation: ***Obstructive Sleep Apnea (Correct Answer)*** - Classic triad: **morbid obesity (BMI 41 kg/m²)**, **excessive daytime somnolence**, and **systemic hypertension (160/100 mmHg)** — hallmarks of OSA - **ABG findings** (PaO2=66 mmHg, PaCO2=50 mmHg, HCO3=28 mEq/L) indicate **chronic nocturnal hypoxemia and hypercapnia** with compensatory **metabolic alkalosis** from repeated apneic episodes - **Cognitive impairment** (impaired concentration and memory) results from **sleep fragmentation** and intermittent nocturnal hypoxia - Obesity promotes **pharyngeal fat deposition** → upper airway narrowing and collapse during sleep → recurrent obstructive events *Narcolepsy* - Causes excessive daytime sleepiness but is **not associated with obesity, hypertension, or ABG abnormalities** - Hallmarks include **cataplexy**, sleep paralysis, and hypnagogic/hypnopompic hallucinations — none present here - Caused by **orexin (hypocretin) deficiency**; associated with **HLA-DQB1*06:02**; ABG is normal *Obesity Hypoventilation Syndrome (OHS / Pickwickian Syndrome)* - Defined as **awake PaCO2 >45 mmHg + BMI >30 kg/m²** with exclusion of other causes of hypoventilation - OHS frequently coexists as an **overlap with and consequence of severe OSA** rather than being the primary diagnosis - In this setting, **OSA is the most prevalent and primary diagnosis**; OHS is specifically considered when awake hypoventilation persists despite adequate OSA treatment *Central Sleep Apnea* - Results from **failure of central respiratory drive** (brainstem), not upper airway obstruction - Associated with **congestive heart failure, opioid use, high-altitude exposure, or neurological disease** — none present here - Not characteristically associated with morbid obesity; clinical and ABG picture here favors an **obstructive** rather than central pattern
Question 25: A 45-year-old obese man presents to his primary care provider for an annual physical. The patient states that he has noticed increased sleepiness during the day at work over the past 6 months in addition to difficulty concentrating and worsening memory. He denies recent weight loss, and is not sure if he snores because he sleeps by himself. His past medical history is significant for hypertension and type II diabetes. Vital signs are T 98.6 F, HR 75 bpm, BP 140/90 mm Hg, RR 18/min. Physical exam reveals a 350 pound man. Jugular venous distension is difficult to evaluate due to excess tissue in the neck. There is no peripheral edema. Lung exam is normal. Routine CBC shows WBC count of 5000 cells/ml, platelet count of 350,000/mcL, hemoglobin of 18 gm/dL, and hematocrit of 54%. What is the most likely cause of his abnormal lab results?
- A. JAK2 mutation
- B. Malignancy
- C. Cor pulmonale
- D. Sleep apnea (Correct Answer)
- E. Diuretic overuse
Explanation: ***Sleep apnea*** - The patient's **obesity**, daytime sleepiness, difficulty concentrating, and high hemoglobin/hematocrit are highly suggestive of **sleep apnea**. The chronic nocturnal hypoxia from sleep apnea triggers increased erythropoietin production, leading to **secondary polycythemia** [2]. - While the patient isn't sure if he snores, the combination of his symptoms and elevated red blood cell parameters in an obese individual makes sleep apnea the most likely cause [2]. *JAK2 mutation* - A **JAK2 V617F mutation** is characteristic of **polycythemia vera**, a myeloproliferative neoplasm, which typically presents with very high hemoglobin and hematocrit and can be associated with symptoms like fatigue and pruritus [1]. However, **secondary polycythemia** due to sleep apnea is a more common cause of elevated red cell counts in an obese patient with these symptoms. - Unlike **secondary polycythemia**, which primarily affects red blood cell production, polycythemia vera often involves increases in all three blood cell lines (panmyelosis), though these are not seen here. *Malignancy* - While some **malignancies** can cause paraneoplastic syndromes leading to polycythemia (e.g., renal cell carcinoma producing erythropoietin), this is typically less common than sleep apnea as a cause of secondary polycythemia in an obese patient with these symptoms. - The patient's general signs and symptoms are more consistent with the chronic issues related to sleep-disordered breathing rather than a specific malignancy. *Cor pulmonale* - **Cor pulmonale** refers to right-sided heart failure due to chronic lung disease or pulmonary hypertension [3]. While chronic hypoxia from severe lung disease can cause **secondary polycythemia**, the patient has a normal lung exam and no peripheral edema or overt signs of right heart failure. - Although sleep apnea can eventually lead to pulmonary hypertension and cor pulmonale, the primary cause of the polycythemia and presenting symptoms in this case is the hypoxia of sleep apnea itself, rather than advanced cor pulmonale. *Diuretic overuse* - **Diuretic overuse** can cause hemoconcentration and apparent increases in hemoglobin and hematocrit due to fluid loss, but it would typically be accompanied by other signs of dehydration or electrolyte abnormalities, and would not explain the patient's severe daytime sleepiness and cognitive issues. - The patient denies recent weight loss and has an elevated blood pressure, making severe dehydration from diuretic overuse less likely.
Question 26: Severe Obstructive sleep apnea is defined as AHI of greater than
- A. 15 events/hour
- B. 30 events/hour (Correct Answer)
- C. 25 events/hour
- D. 20 events/hour
Explanation: ***30 events/hour*** - A **severe form of obstructive sleep apnea (OSA)** is diagnosed when the Apnea-Hypopnea Index (AHI) is greater than or equal to **30 events per hour** [1]. - The AHI represents the average number of **apnea and hypopnea events** per hour of sleep [1]. *15 events/hour* - An AHI of **15 to 30 events/hour** typically defines **moderate sleep apnea**, not severe. - This level indicates a significant number of sleep disturbances, but less than what is categorized as severe. *25 events/hour* - An AHI of **25 events/hour** falls within the **moderate range** of OSA severity (15-30 events/hour). - It does not meet the criteria for severe OSA, which requires a higher AHI. *20 events/hour* - An AHI of **20 events/hour** also falls into the **moderate category** of OSA. - This value is above the threshold for mild OSA (5-15 events/hour) but below the threshold for severe OSA.
Question 27: The sleep apnea syndrome is defined as -
- A. Apnea-Hypopnea Index (AHI) ≥ 5/hour (Correct Answer)
- B. Apnea-Hypopnea Index (AHI) ≥ 10/hour
- C. Apnea-Hypopnea Index (AHI) ≥ 30/hour
- D. Apnea-Hypopnea Index (AHI) ≥ 15/hour
Explanation: ***Apnea-Hypopnea Index (AHI) ≥ 5/hour*** - The definition of **sleep apnea syndrome** generally requires an **AHI of 5 or more events per hour**, often accompanied by symptoms like excessive daytime sleepiness or cardiovascular complications [1]. - This threshold identifies individuals with clinically significant sleep-disordered breathing that warrants further evaluation and potential treatment [1]. *Apnea-Hypopnea Index (AHI) ≥ 10/hour* - While an AHI of 10/hour indicates sleep apnea, it is a higher severity criterion and does not represent the **minimum threshold** for defining the syndrome [1]. - Patients with an AHI between 5 and 10 also have sleep apnea and can experience significant symptoms. *Apnea-Hypopnea Index (AHI) ≥ 30/hour* - An AHI of 30/hour or more signifies **severe sleep apnea**, which requires aggressive management. - This is far above the **general diagnostic threshold** for sleep apnea syndrome. *Apnea-Hypopnea Index (AHI) ≥ 15/hour* - An AHI of 15/hour is typically classified as **moderate sleep apnea**. - This value is higher than the **lowest AHI threshold** used to define the presence of sleep apnea syndrome.
Question 28: What is the minimum diagnostic threshold for obstructive sleep apnoea according to current guidelines?
- A. AHI <5 events per hour
- B. AHI 15-30 events per hour
- C. AHI >30 events per hour (Correct Answer)
- D. AHI 5-15 events per hour
Explanation: AHI >30 events per hour - An Apnoea-Hypopnoea Index (AHI) greater than 30 events per hour indicates severe obstructive sleep apnea (OSA), which is definitively above the minimum diagnostic threshold [1]. - While an AHI of 5 or more is generally considered diagnostic for OSA, an AHI >30 signifies severe disease and often leads to more pronounced symptoms and health risks [1]. *AHI <5 events per hour* - An AHI score of less than 5 events per hour is typically considered normal or within the non-pathological range for sleep-disordered breathing [1]. - Individuals with an AHI below this threshold usually do not meet the diagnostic criteria for any form of sleep apnea. *AHI 15-30 events per hour* - This range indicates moderate obstructive sleep apnea. While it is diagnostic for OSA, it is not the minimum threshold [1]. - Patients in this category often experience significant symptoms and may require treatment, but it is not the lowest AHI at which a diagnosis can be made. *AHI 5-15 events per hour* - This AHI range is considered mild obstructive sleep apnea. An AHI of 5 or more, accompanied by relevant symptoms, is generally the minimum diagnostic threshold for OSA [1]. - However, the question asks for the minimum diagnostic threshold, and while 5 events per hour is a minimum, "AHI >30 events per hour" indicates a clear and severe diagnostic case.
Question 29: Muller's manoeuvre is used to
- A. To remove foreign body from ear
- B. To find degree of obstruction in sleep disordered breathing (Correct Answer)
- C. To remove laryngeal foreign body
- D. To find out opening of mouth
Explanation: ***To find degree of obstruction in sleep disordered breathing*** - **Muller's manoeuvre** is a diagnostic technique where the patient attempts to inspire forcefully against a **closed mouth and nostrils** while an endoscope observes the upper airway. - This maneuver helps to simulate the negative intraluminal pressure that occurs during sleep, making it useful in identifying the **site and severity of airway obstruction** in patients with sleep-disordered breathing. *To remove foreign body from ear* - Removing foreign bodies from the ear typically involves **irrigation**, specialized instruments (e.g., alligator forceps), or suction, not a breathing maneuver. - This option is unrelated to the physiological assessment of airway obstruction. *To remove laryngeal foreign body* - The primary methods for removing laryngeal foreign bodies are the **Heimlich maneuver** (abdominal thrusts) or direct laryngoscopy and removal. - Muller's manoeuvre is a diagnostic procedure, not a therapeutic one for foreign body extraction. *To find out opening of mouth* - Measuring the **opening of the mouth** is typically done with a ruler or specific instruments to assess jaw mobility (e.g., for temporomandibular joint disorders or trismus). - This is a simple measurement and does not involve the complex physiological assessment of the upper airway that Muller's manoeuvre provides.
Question 30: A 42-year-old obese male presented with disturbed sleep and daytime somnolence. All of the following are correct except?
- A. Apnea with hypoxia
- B. Pharyngeal muscle contraction increases OSA (Correct Answer)
- C. Apnea with awakening
- D. Apnea with fall in saturation
Explanation: ***Pharyngeal muscle contraction increases OSA*** - Obstructive sleep apnea (OSA) is caused by the collapse of the upper airway due to the **relaxation** and consequent loss of tone in the **pharyngeal muscles** during sleep, not by their contraction [1]. - While muscle contraction normally helps maintain airway patency, **reduced muscle activity** allows the airway to narrow or collapse. *Apnea with hypoxia* - **Apnea**, defined as a cessation of breathing for at least 10 seconds, often leads to periods of **hypoxia** (decreased blood oxygen levels) due to insufficient gas exchange [1]. - This **recurrent hypoxia** is a hallmark of OSA and contributes to its cardiovascular and neurological consequences. *Apnea with awakening* - Following an apneic episode, the body's protective reflex often causes a brief **arousal or awakening** from sleep to restore airway patency and ventilation [2]. - These frequent **micro-awakenings** are a primary reason for the disturbed sleep and subsequent daytime somnolence experienced by patients with OSA [2]. *Apnea with fall in saturation* - During an apneic event, the lack of airflow into the lungs results in a **decrease in oxygen saturation (SpO2)**, which is a key diagnostic criterion for OSA severity [2]. - This **desaturation** is directly linked to the duration and frequency of apneic episodes.
Question 31: Which of the following statements about obstructive sleep apnea is false?
- A. Apnea is associated with high respiratory effort
- B. Apnea is associated with fall in SpO2
- C. Apnea is associated with sudden awakening
- D. Contraction of pharyngeal muscles can worsen obstruction (Correct Answer)
Explanation: ***Contraction of pharyngeal muscles can worsen obstruction*** - In **obstructive sleep apnea (OSA)**, the pharyngeal muscles are normally responsible for maintaining airway patency [1]. - A *contraction* of these muscles would *open* the airway, whereas *relaxation* or *loss of tone* leads to collapse and obstruction. *Apnea is associated with high respiratory effort* - During an **apneic episode** in OSA, the airway is *obstructed*, leading to continued but **unsuccessful inspiratory efforts** against a closed airway. - This results in a significant increase in **respiratory effort** as the diaphragm and accessory muscles try to overcome the obstruction. *Apnea is associated with fall in SpO2* - The cessation of airflow during **apnea** prevents **gas exchange**, leading to a progressive decrease in **oxygen saturation (SpO2)**. - This **hypoxia** is a hallmark physiological consequence of apneic events and often triggers arousal from sleep [2]. *Apnea is associated with sudden awakening* - The combination of **hypoxia** and **hypercapnia** (increased CO2), along with the increased respiratory effort, stimulates the central nervous system [2]. - This stimulation causes a **brief arousal or awakening** from sleep, often accompanied by gasping or snorting, to re-establish airway patency.
Question 32: A patient presents with snoring and excessive daytime sleepiness. What is the initial investigation of choice?
- A. Laryngoscopy
- B. Polysomnography (Correct Answer)
- C. MRI of the neck
- D. Echocardiography
Explanation: ***Polysomnography*** - This is the **gold standard** for diagnosing **sleep apnea**, which is characterized by snoring and excessive daytime sleepiness. - It records multiple physiological parameters during sleep, including **brain activity, oxygen levels, heart rate, and breathing patterns**. *Laryngoscopy* - This procedure examines the larynx and vocal cords; it is commonly used for evaluating **hoarseness or throat pain**, not primary sleep disorders. - While it can identify structural abnormalities in the upper airway, it doesn't assess the **physiological impact** of these abnormalities during sleep. *MRI of the neck* - This imaging technique provides detailed anatomical views of soft tissues in the neck, which can identify **structural airway obstruction** in specific cases. - However, it does not assess the dynamic physiological changes occurring during sleep that lead to conditions like **obstructive sleep apnea**. *Echocardiography* - This test is used to evaluate the **heart's structure and function**, primarily for cardiac issues like heart failure or valvular disease. - While sleep apnea can have cardiovascular consequences, **echocardiography** is not an initial diagnostic tool for the sleep disorder itself.
Question 33: What AHI range indicates MILD obstructive sleep apnea?
- A. 5 - 15 (Correct Answer)
- B. 15 - 30
- C. >30
- D. <5
Explanation: **5 - 15** - An **Apnea-Hypopnea Index (AHI)** between **5 and 15** events per hour signifies **mild obstructive sleep apnea (OSA)** [1]. - This classification helps guide treatment decisions, as mild OSA may respond to lifestyle modifications or oral appliances [1]. *<5* - An AHI of **less than 5** events per hour is generally considered **normal** or indicative of no significant sleep apnea [1]. - While some individuals may have mild symptoms with an AHI below 5, it typically does not meet the diagnostic criteria for OSA [1]. *15 - 30* - An AHI in this range indicates **moderate obstructive sleep apnea**. - Patients with moderate OSA often experience more pronounced symptoms and typically require intervention such as **Continuous Positive Airway Pressure (CPAP)** therapy. *>30* - An AHI **greater than 30** events per hour is classified as **severe obstructive sleep apnea**. - This level of severity is associated with significant health risks and almost always necessitates immediate and effective treatment like **CPAP**.
Question 34: The Apnea-Hypopnea Index (AHI) is specifically used for diagnosing and assessing the severity of which condition?
- A. Emphysema
- B. Asthma
- C. Hyaline membrane disease
- D. Obstructive sleep apnea (OSA) (Correct Answer)
Explanation: ***Obstructive sleep apnea (OSA)*** - The **Apnea-Hypopnea Index (AHI)** quantifies the average number of apneas and hypopneas per hour of sleep, which is the primary metric for diagnosing and determining the severity of OSA [1]. - An apnea is a complete cessation of airflow, while a hypopnea is a significant reduction in airflow, both leading to **oxygen desaturation** and sleep disruption [1]. *Emphysema* - Emphysema is a form of **Chronic Obstructive Pulmonary Disease (COPD)** characterized by destruction of the alveoli, leading to reduced gas exchange. - Its diagnosis and severity assessment rely on **spirometry** (e.g., FEV1/FVC ratio) and imaging, not AHI [2]. *Asthma* - Asthma is a chronic inflammatory airway disease characterized by **reversible airway obstruction** and bronchial hyperresponsiveness [2]. - Its diagnosis involves **pulmonary function tests** like spirometry, often with bronchodilator challenge, and clinical symptoms, but not AHI [2]. *Hyaline membrane disease* - **Hyaline membrane disease** (also known as Infant Respiratory Distress Syndrome) is a respiratory disorder primarily affecting premature infants due to insufficient surfactant production. - Diagnosis is based on **clinical presentation** at birth, chest X-rays, and arterial blood gas analysis, not AHI.
Question 35: What is the minimum duration of apnea defined in obstructive sleep apnea?
- A. >=10 sec (Correct Answer)
- B. 20 sec
- C. 15 sec
- D. 5 sec
Explanation: ***>=10 sec*** - An **apnea event** in obstructive sleep apnea (OSA) is defined as a cessation of airflow for at least **10 seconds** [1] during sleep. - This duration is crucial for distinguishing between normal respiratory pauses and clinically significant apneas. *5 sec* - A 5-second period of no airflow is generally considered a **normal physiological variation** or a brief pause, not meeting the criteria for apnea in OSA. - Such brief pauses typically do not lead to significant **oxygen desaturation** [1] or arousal from sleep. *15 sec* - While 15 seconds would certainly qualify as an apnea event, the **minimum threshold** for definition is 10 seconds [1]. - Longer durations of apnea are indicative of more **severe airflow obstruction**, but the 10-second mark is the standard lower limit. *20 sec* - Similarly, 20 seconds represents a **prolonged apnea event**, but it is not the **minimum duration** for diagnosis. - Apneas lasting 20 seconds or more are associated with greater **physiological stress** and more noticeable clinical symptoms.
Question 36: Which of the following statements about obstructive sleep apnea is true?
- A. Nocturnal asphyxia
- B. Alcoholism is a cofactor
- C. Prone to hypertension (Correct Answer)
- D. Overnight oximetry alone is sufficient for diagnosing obstructive sleep apnea.
Explanation: ***Prone to hypertension*** - Obstructive sleep apnea (OSA) is strongly associated with **hypertension** due to recurrent episodes of hypoxemia, hypercapnia, and increased sympathetic activity. - The repeated arousals and stress responses during sleep cause a persistent elevation in blood pressure. [1] *Nocturnal asphyxia* - While OSA involves episodes of **apnea** and **hypopnea** (reduced breathing), the term **asphyxia** implies complete cessation of breathing leading to severe oxygen deprivation and CO2 retention, which is generally not the typical presentation of OSA as patients usually eventually gasp for air. [1] - OSA is characterized by partial or complete **upper airway obstruction** during sleep, leading to reduced airflow and oxygen desaturation, but not usually full asphyxia. [1] *Alcoholism is a cofactor* - **Alcohol consumption**, particularly before bedtime, acts as an **exacerbating factor** for OSA by causing muscle relaxation in the upper airway, but it is not typically considered a primary cofactor in the development of the condition itself. - While alcohol can worsen OSA symptoms and severity, it is not a direct underlying cause in the way obesity or anatomical abnormalities are. *Overnight oximetry alone is sufficient for diagnosing obstructive sleep apnea.* - **Overnight oximetry** can detect oxygen desaturations but is **not sufficient** for a definitive diagnosis of OSA, as it does not measure airflow, respiratory effort, or sleep stages. - A definitive diagnosis requires a **polysomnography (PSG)**, which records multiple physiological parameters including airflow, respiratory effort, oxygen saturation, heart rate, and brain activity.
Question 37: What is the most reliable diagnostic tool to differentiate between psychological and organic erectile dysfunction?
- A. Nocturnal penile tumescence (Correct Answer)
- B. PIPE therapy
- C. Sildenafil induced erection
- D. Squeeze technique
Explanation: ***Nocturnal penile tumescence*** - This diagnostic tool assesses whether a man experiences erections during sleep, which are naturally occurring physiological events. The presence of normal nocturnal erections indicates intact **neurovascular pathways** necessary for erection, suggesting that any daytime erectile dysfunction is likely due to **psychological factors** [2]. - Conversely, the absence of nocturnal erections points towards an **organic cause** for erectile dysfunction, as the physiological mechanism itself is impaired [1]. *Squeeze technique* - The squeeze technique is a behavioral therapy used to treat **premature ejaculation**, not erectile dysfunction. It involves stopping stimulation at the point of impending ejaculation and applying pressure to the glans to reduce arousal. - This technique does not provide any diagnostic information regarding the underlying cause (psychological vs. organic) of erectile dysfunction. *Sildenafil induced erection* - While sildenafil (Viagra) can induce an erection in many men with erectile dysfunction, its response does not reliably differentiate between psychological and organic causes. Sildenafil works by enhancing the effects of **nitric oxide**, leading to increased blood flow to the penis. - Both men with psychological erectile dysfunction and some with organic causes (e.g., mild vascular compromise) may respond to sildenafil, so a positive response does not rule out an **organic etiology**. *PIPE therapy* - "PIPE therapy" is not a recognized medical or diagnostic term for erectile dysfunction. It may be a typo or a misnomer. - Therefore, it does not serve as a diagnostic tool for differentiating between psychological and organic causes of erectile dysfunction.
Question 38: A 56-year-old woman with diabetes, hypertension, and hyperlipidemia is found to have an A1C of 11 despite her best attempts at diet and faithfully taking her metformin and glyburide. She reports severe fatigue and sleepiness in the daytime, which has limited her ability to exercise. On examination, she is obese, has a full appearing posterior pharynx, clear lungs, a normal heart examination, and trace bilateral edema. Her TSH is 2.0 m/L (normal). Before adding another oral agent or switching to insulin, what is the best next step?
- A. Arrange for a sleep study to check the patient for obstructive sleep apnea. (Correct Answer)
- B. Consider prescribing a sleep aid to help her sleep better and increase her energy to exercise during the day.
- C. Assess for possible depression as a contributor to her fatigue.
- D. Educate the patient on sleep hygiene as a supportive measure to improve her overall well-being.
Explanation: A 56-year-old woman with diabetes, hypertension, and hyperlipidemia is found to have an A1C of 11 despite her best attempts at diet and faithfully taking her metformin and glyburide. She reports severe fatigue and sleepiness in the daytime, which has limited her ability to exercise. On examination, she is obese, has a full appearing posterior pharynx, clear lungs, a normal heart examination, and trace bilateral edema. Her TSH is 2.0 m/L (normal). Before adding another oral agent or switching to insulin, what is the best next step? ***Arrange for a sleep study to check the patient for obstructive sleep apnea.*** - The patient's presentation with **severe fatigue**, **daytime sleepiness**, **obesity**, and a **full-appearing posterior pharynx** are highly suggestive of **obstructive sleep apnea (OSA)** [1]. - OSA can lead to **insulin resistance** and worsen glycemic control, making it a critical factor to address before escalating diabetes medications. *Consider prescribing a sleep aid to help her sleep better and increase her energy to exercise during the day.* - Prescribing a sleep aid without investigating the cause of her sleep disturbances could mask a serious underlying condition like **OSA**, which requires specific treatment [1]. - While improved sleep might transiently boost energy, it would not address the **pathophysiology of OSA** or its impact on diabetes. *Assess for possible depression as a contributor to her fatigue.* - While **depression** can cause fatigue and impact exercise, her physical findings (obesity, full pharynx) and the specific symptom of **daytime sleepiness** point more strongly towards a primary sleep disorder like OSA [1]. - A definitive diagnosis of OSA would better explain the combination of her symptoms and poor glycemic control. *Educate the patient on sleep hygiene as a supportive measure to improve her overall well-being.* - **Sleep hygiene** is important for overall health, but it is unlikely to resolve severe daytime sleepiness and fatigue caused by a mechanical obstruction like in **OSA** [1]. - This intervention would be insufficient to address the potential link between her sleep disorder and uncontrolled diabetes.
Question 39: Patient with obstructive sleep apnea-hypopnea syndrome is unlikely to have which of the following?
- A. Absence of snoring
- B. Bradycardia during sleep episodes (Correct Answer)
- C. Normal oxygen saturation throughout sleep
- D. Decreased neck circumference
Explanation: ***Bradycardia during sleep episodes*** - While patients with **obstructive sleep apnea (OSA)** commonly experience various cardiovascular complications, **bradycardia** during apneic episodes is *less typical* than **tachycardia**. - The body's initial response to apnea and **hypoxia** usually involves a sympathetic surge leading to tachycardia upon arousal, followed by bradycardia if the apnea is prolonged. However, the dominant pattern is often elevated heart rate variability. *Normal oxygen saturation throughout sleep* - Patients with OSA frequently experience intermittent **hypoxemia** due to repeated apneas and hypopneas, leading to significant drops in **oxygen saturation** [1]. - A *normal oxygen saturation throughout sleep* would effectively rule out significant OSA, as desaturation is a hallmark of the condition [1]. *Absence of snoring* - **Snoring** is a classic and highly prevalent symptom of OSA, caused by the vibration of upper airway tissues as air struggles to pass through an obstructed pharynx. - While not all snorers have OSA, the *absence of snoring* makes OSA less likely, although it can occur in some subsets of patients, particularly those with central sleep apnea or certain anatomical variations. *Decreased neck circumference* - A **large neck circumference** is a well-established anatomical risk factor for OSA, indicating increased soft tissue in the neck that can contribute to upper airway collapse. - A *decreased neck circumference* would generally be protective against OSA, making it less likely for an individual to have the condition.
Question 40: All of the following criteria are required for diagnosis of obesity hypoventilation syndrome except -
- A. PaCO2 > 45 mmHg
- B. BMI 30 kg/m2
- C. Hypertension (Correct Answer)
- D. Sleep disorder breathing
Explanation: ***Hypertension*** - While **hypertension** is a common comorbidity in patients with **obesity hypoventilation syndrome (OHS)**, it is _not_ a diagnostic criterion. - OHS is defined by specific respiratory and obesity-related parameters, not the presence of associated cardiovascular conditions. *BMI $\geq$ 30 kg/m$^2$* - A **body mass index (BMI)** of **30 kg/m$^2$** or greater is a fundamental criterion for diagnosing OHS, as the syndrome is directly linked to obesity. - Severe obesity leads to mechanical compression of the lungs and chest wall, contributing to hypoventilation. *PaCO$_{2}$ > 45 mmHg* - A **daytime arterial partial pressure of carbon dioxide (PaCO$_{2}$)** greater than **45 mmHg** is a key diagnostic criterion, indicating chronic alveolar hypoventilation. - This persistent hypercapnia is present even when other causes like obstructive lung disease have been excluded. *Sleep-disordered breathing* - **Sleep-disordered breathing**, most commonly **obstructive sleep apnea (OSA)**, is almost universally present in OHS patients and is a required diagnostic criterion [1]. - The combination of severe obesity and OSA often leads to the development of chronic hypoventilation [1].
Question 41: What is the minimum number of apnea episodes required for the diagnosis of obstructive sleep apnea?
- A. AHI ≥ 10 events/hour
- B. AHI ≥ 2 events/hour
- C. AHI ≥ 5 events/hour (Correct Answer)
- D. AHI ≥ 4 events/hour
Explanation: ***AHI ≥ 5 events/hour*** - An **apnea-hypopnea index (AHI)** of 5 or more events per hour of sleep, accompanied by symptoms such as **daytime sleepiness**, snoring, or witnessed apneas, is the diagnostic criterion for obstructive sleep apnea (OSA) [1]. - This threshold signifies a clinically significant frequency of **breathing disturbances** during sleep [1]. *AHI ≥ 2 events/hour* - An AHI of 2 events/hour is generally considered within the **normal range** or indicates very mild, non-pathological sleep disordered breathing. - It is **insufficient** to diagnose OSA in adults, even with associated symptoms. *AHI ≥ 10 events/hour* - An AHI of 10 events/hour would indicate at least **mild to moderate OSA**, well above the minimum diagnostic threshold. - While diagnostic, it is not the *minimum* number required for initial diagnosis. *AHI ≥ 4 events/hour* - An AHI of 4 events/hour is close to the diagnostic threshold but still **below the minimum** required for a formal diagnosis of OSA. - It would typically be considered **mild sleep-disordered breathing** that may not meet diagnostic criteria without other significant factors.
Practice by Chapter
Normal Sleep Physiology
Practice Questions
Sleep-Disordered Breathing
Practice Questions
Insomnia
Practice Questions
Hypersomnias
Practice Questions
Circadian Rhythm Disorders
Practice Questions
Parasomnias
Practice Questions
Sleep-Related Movement Disorders
Practice Questions
Sleep in Medical Disorders
Practice Questions
Sleep in Psychiatric Disorders
Practice Questions
Sleep Diagnostics
Practice Questions
Pharmacologic Management of Sleep Disorders
Practice Questions
Non-pharmacologic Sleep Interventions
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free